^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    NSD3 overexpression

    i
    Other names: NSD3, Nuclear Receptor Binding SET Domain Protein 3, WHISTLE, WHSC1L1, KMT3F, Wolf-Hirschhorn Syndrome Candidate 1-Like 1, Histone-Lysine N-Methyltransferase NSD3, Nuclear SET Domain-Containing Protein 3, Protein Whistle, FLJ20353, WHSC1-Like 1 Isoform 9 With Methyltransferase Activity To Lysine, Wolf-Hirschhorn Syndrome Candidate 1-Like Protein 1, WHSC1-Like Protein 1, Pp14328, KMT3G
    Entrez ID:
    54904
    over2years
    PROGNOSTIC RELEVANCE AND ANTITUMOR OR IMMUNITY OF NSD3 OVEREXPRESSION IN THE BREAST CANCER (GBCC 2022)
    WHSC1L1 overexpression could play potential roles in the progression of breast cancer, and targeting WHSC1L1 could be a potential strategy for the treatment of breast cancer.
    PD(L)-1 Biomarker • IO biomarker
    |
    CD8 (cluster of differentiation 8) • NSD3 (Nuclear Receptor Binding SET Domain Protein 3)
    |
    PD-L1 expression • NSD3 overexpression
    |
    erlotinib • VTX-11e • LY2109761 • CZC24832